时间：2026-09-23 03:15:23 来源：网络整理编辑：百科
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a patient’s physician or caregiver when it’s been ingested, the agency announced on Monday.
The Japanese drug maker Otsuka Pharmaceutical won the approval for an upgraded version of Abilify, the antipsychotic drug first approved 15 years ago to treat schizophrenia, bipolar disorder, and depression. Otsuka collaborated with Proteus Digital Health, the Silicon Valley company that designed the futuristic sensor technology.
SEE ALSO:Big Pharma’s big push to get patients to take their medsThe new product, which will be sold as Abilify MyCite, can be swallowed just like any other pill. When that happens, the ingestible sensor inside it sends a message to a patch worn by the patient, which then transmits the information to a mobile app that the patient can monitor. If a patient opts to allow it, the patient’s caregivers and doctor can access the data online, too.
The FDA’s decision Monday comes a year and a half after the agency rejected the product. At the time, the agency said it needed more information about how the product is used and how human error could create risks. Monday’s hard-won approval could come as a big boost for Otsuka, which had lost market share after Abilify went generic but will now have a way to make the product stand out.
Forgetfulness and cloudy thinking can be symptoms of the mental health conditions that Abilify is approved to treat, and patients with mental illness are known to struggle to take medication consistently. But the new product will also be labeled with a caveat: There’s no evidence that the technology can help patients take their medication as prescribed.
The landmark approval is the latest in an expansive rethinking of what constitutes a treatment. In September, the FDA approved the first mobile app to treat certain substance use disorders, developed by the Boston company Pear Therapeutics.
TopicsHealth
MashReads Podcast: What makes a good summer read?2026-09-23 03:04
重慶外援“大摩托”已抵達廣州 烏茲別克中衛加盟在即2026-09-23 02:36
津媒宣布於根偉任津門虎總經理兼主帥 俱樂部官微未發聲2026-09-23 02:36
陳戌源懇請俱樂部保護好國腳 將出台新裁判評判機製2026-09-23 02:34
How Hyperloop One went off the rails2026-09-23 02:08
曝前江蘇隊球員葉重秋加盟武漢 曾效力上海申鑫2026-09-23 01:52
重慶外援“大摩托”已抵達廣州 烏茲別克中衛加盟在即2026-09-23 01:48
中超不出意外將按既定日程開賽 並非全部場次開門迎客2026-09-23 01:45
This 'sh*tpost' bot makes terrible memes so you don't have to2026-09-23 01:15
2021三級聯賽升降級規則:中甲前2升超 中超152026-09-23 00:46
Metallica to seek and destroy your eardrums with new album this fall2026-09-23 03:00
洛裏已為法國出場123次 追平亨利並列隊史第二2026-09-23 02:52
伊布豪言 ：我定能摧毀金剛 向巴頓一樣越來越年輕2026-09-23 02:44
阿圭羅為團聚梅西願降薪投巴薩 接受次要角色定位2026-09-23 02:30
These glasses hide a fitness tracker on your face2026-09-23 02:23
迷惑行為 ！伊卡爾迪曬與旺達合影 ：這是我的母狗2026-09-23 02:03
匪夷所思 ！西班牙門將貿然出擊 給對手送上“大禮”2026-09-23 01:44
曝津門虎欠薪總額不到三億 泰達控股將落實解決2026-09-23 01:44
Chinese gymnastics team horrifies crowd with human jump rope2026-09-23 01:05
門線冤案再現！比利時大將好球被吹 錯失戴帽良機2026-09-23 00:32
